Preferred Label : Erdafitinib;

NCIt synonyms : 1,2-Ethanediamine, N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-(3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl)-;

NCIt definition : An orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity. Upon oral administration, erdafitinib binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal transduction pathways and thus the inhibition of tumor cell proliferation and tumor cell death in FGFR-overexpressing tumor cells. FGFR, upregulated in many tumor cell types, is a receptor tyrosine kinase essential to tumor cell proliferation, differentiation and survival.;

UNII : 890E37NHMV;

InChIKey : OLAHOMJCDNXHFI-UHFFFAOYSA-N;

CAS number : 1346242-81-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1346242-81-6 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Balversa;

Molecule name : JNJ-42756493;

Codes from synonyms : 196;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3506762/fr/balversa-erdafitinib-carcinome-urothelial
2024
false
false
false
France
erdafitinib
administration, oral
Product containing only erdafitinib in oral dose form (medicinal product form)
evaluation of the transparency committee
erdafitinib
erdafitinib
Erdafitinib

---
Nous contacter.
16/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.